Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Citi
Teva
Baxter
Mallinckrodt
Queensland Health
Dow
Federal Trade Commission
QuintilesIMS

Generated: July 22, 2018

DrugPatentWatch Database Preview

Actavis Elizabeth Company Profile

« Back to Dashboard

What is the competitive landscape for ACTAVIS ELIZABETH, and what generic and branded alternatives to ACTAVIS ELIZABETH drugs are available?

ACTAVIS ELIZABETH has one hundred and twenty-three approved drugs.

There are eight tentative approvals on ACTAVIS ELIZABETH drugs.

Drugs and US Patents for Actavis Elizabeth

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 088560-001 Oct 4, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Actavis Elizabeth PRAMIPEXOLE DIHYDROCHLORIDE pramipexole dihydrochloride TABLET, EXTENDED RELEASE;ORAL 201963-005 Apr 21, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Actavis Elizabeth CLONAZEPAM clonazepam TABLET;ORAL 074869-001 Oct 31, 1996 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Actavis Elizabeth OXAPROZIN oxaprozin TABLET;ORAL 075843-001 Oct 3, 2001 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Moodys
Fish and Richardson
Mallinckrodt
Johnson and Johnson
US Army
Cantor Fitzgerald
UBS
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.